A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome

Clinical trial NCT00999518 · TERMINATED

Trial details

NCT number: NCT00999518
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Cystitis, Interstitial

Start date: 2010-01-22
Primary completion: 2010-11-17
Enrollment: 205

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.